The Swedish Nationwide Experience of Converting Transplant Patients Treated With Sandimmun to the New Galenic Formulation Sandimmun-Neoral

By Swedish Sandimmun-Neoral Conversion Group   Wilczek H.E.   Berglin E.   Blohme I.   Backman L.   Fehrman I.   Kallen R.   Nyberg G.   Sawe J.   Wahlberg J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 280-283

Elsevier

Access to resources Recommend Favorite

Comparative pharmacokinetic study of neoral vs sandimmun in Japanese stable renal allograft recipients

By Takahara S.   Ohta K.   Ohashi Y.   Namii Y.   Uchida K.   Okuyama A.   Kainuma H.   Takagi H.   Takahashi K.   Morikawa H.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3089-3092

Elsevier

Access to resources Recommend Favorite

Comparison of Efficacy, Safety, and Tolerability of Neoral vs Sandimmun in De Novo Renal Transplant Patients Over 24 Months' Treatment

By Abendroth D.   Buchholz B.   Land W.   May G.   Wiesel M.   Farber L.   Korn A.   Maibucher A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 275-276

Elsevier

Access to resources Recommend Favorite

Neoral vs Sandimmun: Interim Results of a Randomized Trial of Efficacy and Safety in Preventing Acute Rejection in New Renal Transplant Recipients

By U.K. Neoral Study Group   Lodge J.P.A.   Pollard S.G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 272-273

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of conversion from once daily sandimmun to twice daily neoral cyclosporine in renal allograft recipients

By Vathsala A.   Lee W.T.   Lu Y.-M.   Woo K.T.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1746-1748

Elsevier

Access to resources Recommend Favorite